Irinotecan in the treatment of colorectal cancer
- 1 November 2006
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 32 (7) , 491-503
- https://doi.org/10.1016/j.ctrv.2006.07.001
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Cancer Statistics, 2005CA: A Cancer Journal for Clinicians, 2005
- Cancer Statistics, 2004CA: A Cancer Journal for Clinicians, 2004
- Moving beyond Fluorouracil for Colorectal CancerNew England Journal of Medicine, 2000
- Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal CancerNew England Journal of Medicine, 2000
- Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trialPublished by Elsevier ,2000
- Toxicity of fluorouracil in patients with advanced colorectal cancer: effect of administration schedule and prognostic factors. Meta-Analysis Group In Cancer.Journal of Clinical Oncology, 1998
- Genetic predisposition to the metabolism of irinotecan (CPT-11). Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes.Journal of Clinical Investigation, 1998
- Effect of CPT on the DNA cleavage/religation reaction mediated by calf thymus Topoisomerase I: evidence of an inhibition of DNA religationMolecular Biology Reports, 1995
- Appendix I: An Introduction to DNA Supercoiling and DNA Topoisomerase-Catolyzed Linking Number Changes of Supercoiled DNAPublished by Elsevier ,1994
- Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project.Journal of Clinical Oncology, 1992